New Delhi: The Union Budget 2026–27 has set the stage for India to emerge as a global biopharmaceutical hub with the launch of Biopharma SHAKTI, a ₹10,000 crore initiative over five years. The program aims to strengthen the country’s capabilities in biologics and biosimilars, reduce import dependence, and capture 5%…
Tag: #Biosimilars
News
India’s Pharma & Medical Devices Drive Value Growth
India’s pharmaceutical and medical devices sectors are undergoing a transformative shift, moving from a volume-driven model to a value-focused approach. The Economic Survey 2025-26 emphasizes the country’s growing focus on complex generics, biosimilars, and innovative medical technologies, positioning India as a global hub for high-value healthcare manufacturing. Medical Devices Industry…
News
India’s Pharma Push: OPPI Summit Urges “Lab of the World”
At the 60th Annual Summit of the Organisation of Pharmaceutical Producers of India (OPPI), government leaders and experts called for a decisive shift from large-scale manufacturing to high-value research and innovation, underlining partnerships as the engine of India’s next phase in pharmaceuticals. “Laboratory of the World” — a national call…
News
Defence Atmanirbharta: Record Production & Rising Exports
India recorded a record ₹1.54 lakh crore in defence production in FY 2024–25 while defence exports surged to ₹23,622 crore milestones that underline the success of sustained policy reforms, expanding private-sector participation and a growing defence manufacturing ecosystem dominated by thousands of MSMEs. Numbers that mark a turning point Indigenous…